# Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold Urticaria

> **NCT01605487** · PHASE2 · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 24 (actual)

## Conditions studied

- Cold Contact Urticaria

## Interventions

- **DRUG:** Rupatadine
- **DRUG:** Rupatadine
- **DRUG:** Rupatadine
- **DRUG:** Rupatadine
- **DRUG:** Rupatadine
- **DRUG:** Rupatadine

## Key facts

- **NCT ID:** NCT01605487
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-09
- **Final completion:** 2014-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2014-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01605487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01605487, "Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold Urticaria". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01605487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*